Dinaciclib 70 is a selective inhibitor of cyclin-dependent kinases (CDKs), CDK1,2,5,9, used to induce pyroptosis in melanoma through caspase-1/GSDME/Bax activation [186]. The gene discussed is GSDME; the disease is melanoma.